Article info

Download PDFPDF
Original research article
Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease

Authors

  1. Correspondence to Suzette J Bielinski, Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Harwick Building 6-56, 200 First Street Southwest, Rochester, MN 55905, USA; bielinski.suzette{at}mayo.edu
View Full Text

Citation

Bielinski SJ, Berardi C, Decker PA, et al
Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease

Publication history

  • Received August 11, 2016
  • Revised January 19, 2017
  • Accepted January 27, 2017
  • First published June 1, 2017.
Online issue publication 
January 18, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.